Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trial.
about
Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@ast
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@en
type
label
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@ast
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@en
prefLabel
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@ast
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@en
P2093
P1476
Safety and immunogenicity of 2 ...... nd, randomized clinical trial.
@en
P2093
Fengcai Zhu
Jichun Shi
Wenjin Wei
P2860
P304
P356
10.1080/21645515.2015.1011015
P577
2015-01-01T00:00:00Z